Neptune to use proceeds of private placement to fund SugarLeaf acquisition, significant shareholder participation

Flower One and Deuces 22 to bring premium lifestyle cannabis brand to Nevada

As a means of providing immediate pain relief for cancer patients, scientists have begun conducting clinical research on delivering medical cannabis concentrates through an inhaler. This new method of delivery will increase accessibility for cancer patients who are treated with long-term pharmaceutical cannabis (such as sublingual tablets), and those suffering…

It may have taken scientists 13 years to sequence the human genome’s 30,000-40,000 genes, but times have changed, and so has the target. Having been ignored by the scientific-medical establishment for decades, cannabis has begun to garner the attention of serious scientists. Whether this is due to a changing regulatory…

If we take a brief look back at history it’s clear that cannabis has survived several societal reputations. What was once known as “Devil’s Lettuce,” went on to be a pop culture symbol of Bob Marley. Today, the shift of the plant’s perception is a direct correlation to recent mass…

The Seed Investor’s full weekly wrap-up of major news in the cannabis industry and our look at the important trends.